The Brazilian Health Regulatory Agency (ANVISA) launched a guided public consultation, aimed at collecting public contributions to a new Regulatory Agenda for the 2021-2023 period. Under a new format, the consultation proposes 106 key regulatory projects, classified in 15 macro-themes, to compose ANVISA’s regulatory prioritization for the next three years.